Trials / Conditions / Pulmonary Carcinoid Tumor
Pulmonary Carcinoid Tumor
5 registered clinical trials studyying Pulmonary Carcinoid Tumor.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs NCT04915144 | British Columbia Cancer Agency | Phase 2 |
| Completed | Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors NCT02259725 | University of Southern California | Phase 2 |
| Terminated | Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors NCT00084461 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma NCT00093782 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074 | National Cancer Institute (NCI) | Phase 1 |